Management of hypertension in diabetes

C. Arauz-Pacheco, Philip Raskin

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The prevalence of hypertension is increased approximately two-fold in the diabetic population. Hypertension elevates the risk of morbidity and mortality from macrovascular and microvascular complications of diabetes. Effective antihypertensive treatment decreases the progression of diabetic nephropathy. ACE inhibitors may have a specific renal protective effect in patients with early diabetic nephropathy. There are few, nonconclusive data concerning the effects of antihypertensives on other diabetic complications. Diuretics should be avoided in diabetic patients since their use may increase the cardiovascular mortality in this group of patients. Therapeutic approaches to patients with IDDM, NIDDM, and patients with diabetic complications are discussed.

Original languageEnglish (US)
Pages (from-to)371-394
Number of pages24
JournalEndocrinology and Metabolism Clinics of North America
Volume21
Issue number2
StatePublished - 1992

Fingerprint

Medical problems
Antihypertensive Agents
Hypertension
Diabetes Complications
Angiotensin-Converting Enzyme Inhibitors
Diuretics
Diabetic Nephropathies
Mortality
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Morbidity
Kidney
Therapeutics
Population

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Management of hypertension in diabetes. / Arauz-Pacheco, C.; Raskin, Philip.

In: Endocrinology and Metabolism Clinics of North America, Vol. 21, No. 2, 1992, p. 371-394.

Research output: Contribution to journalArticle

@article{492042980c1e46e0926eb2c42b40d776,
title = "Management of hypertension in diabetes",
abstract = "The prevalence of hypertension is increased approximately two-fold in the diabetic population. Hypertension elevates the risk of morbidity and mortality from macrovascular and microvascular complications of diabetes. Effective antihypertensive treatment decreases the progression of diabetic nephropathy. ACE inhibitors may have a specific renal protective effect in patients with early diabetic nephropathy. There are few, nonconclusive data concerning the effects of antihypertensives on other diabetic complications. Diuretics should be avoided in diabetic patients since their use may increase the cardiovascular mortality in this group of patients. Therapeutic approaches to patients with IDDM, NIDDM, and patients with diabetic complications are discussed.",
author = "C. Arauz-Pacheco and Philip Raskin",
year = "1992",
language = "English (US)",
volume = "21",
pages = "371--394",
journal = "Endocrinology and Metabolism Clinics of North America",
issn = "0889-8529",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Management of hypertension in diabetes

AU - Arauz-Pacheco, C.

AU - Raskin, Philip

PY - 1992

Y1 - 1992

N2 - The prevalence of hypertension is increased approximately two-fold in the diabetic population. Hypertension elevates the risk of morbidity and mortality from macrovascular and microvascular complications of diabetes. Effective antihypertensive treatment decreases the progression of diabetic nephropathy. ACE inhibitors may have a specific renal protective effect in patients with early diabetic nephropathy. There are few, nonconclusive data concerning the effects of antihypertensives on other diabetic complications. Diuretics should be avoided in diabetic patients since their use may increase the cardiovascular mortality in this group of patients. Therapeutic approaches to patients with IDDM, NIDDM, and patients with diabetic complications are discussed.

AB - The prevalence of hypertension is increased approximately two-fold in the diabetic population. Hypertension elevates the risk of morbidity and mortality from macrovascular and microvascular complications of diabetes. Effective antihypertensive treatment decreases the progression of diabetic nephropathy. ACE inhibitors may have a specific renal protective effect in patients with early diabetic nephropathy. There are few, nonconclusive data concerning the effects of antihypertensives on other diabetic complications. Diuretics should be avoided in diabetic patients since their use may increase the cardiovascular mortality in this group of patients. Therapeutic approaches to patients with IDDM, NIDDM, and patients with diabetic complications are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0026708868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026708868&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 371

EP - 394

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

SN - 0889-8529

IS - 2

ER -